Produk Naam: Dehidronandroloon asetaat
Sinonieme: Dehidronandroloon asetaat;Dehydronandrolone-6 Acetate
CAS: 2590-41-2
MF: C20H26O3
MW: 314.42
LP: 95-98°C
Berging temp: Beheerde stof, -20°C Vrieskas
Voorkoms: wit poeier
Dehydronandrolone acetate is a key intermediate for the synthesis of fulvestrant (faslodex) and tibolone, while the former was an anti-breast-cancer drug developed by AstraZeneca Company and the latter was a synthetic steroid marketed by Organon Company for post climacteric complains. It is an effective compound that produces quality, langdurige spiertoename. Dit is as gevolg van die relatief lang halfleeftyd van die geneesmiddel. Gebruikers rapporteer ligte newe-effekte, met die grootste newe-effek is waterretensie.
Dehydronandrolon acetate(CAS: 2590-41-2) is an effective compound that produces quality, langdurige spiertoename. Dit is as gevolg van die relatief lang halfleeftyd van die geneesmiddel. Gebruikers rapporteer ligte newe-effekte, met die grootste newe-effek is waterretensie.
Dehydronandrolon acetate is an effective compound that produces quality, langdurige spiertoename,met die grootste newe-effek is waterretensie.
| Items van ontleding |
Spesifikasie |
Resultate |
| Beskrywing |
Wit tot liggeel kristallyne poeier |
Wit kristallyne poeier |
| Smeltpunt |
≥100℃ |
107℃ |
| Spesifieke optiese rotasie |
-20°～-26° |
-22.5° |
| Verlies op droog |
≤0,5% |
0.15% |
| Identifikasie |
Test preparation has maximum
absorption at 282±2nm by
ultraviolet – visible spectrophotometry. |
Gekwalifiseerd |
| Maximum single impurity |
≤1,0% |
0.3% |
| Totale onsuiwerhede |
≤5,0% |
0.8% |
| Assay |
≥95,0% |
99.45% |
| Gevolgtrekking |
Gekwalifiseerd |
